ID: ALA5198110

Max Phase: Preclinical

Molecular Formula: C12H12N6O2

Molecular Weight: 272.27

Associated Items:

Representations

Canonical SMILES:  OCc1cn(-c2cccc(-n3cc(CO)nn3)c2)nn1

Standard InChI:  InChI=1S/C12H12N6O2/c19-7-9-5-17(15-13-9)11-2-1-3-12(4-11)18-6-10(8-20)14-16-18/h1-6,19-20H,7-8H2

Standard InChI Key:  NBNVJYCFYDUZGD-UHFFFAOYSA-N

Associated Targets(non-human)

Ribonuclease pancreatic 177 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 272.27Molecular Weight (Monoisotopic): 272.1022AlogP: -0.17#Rotatable Bonds: 4
Polar Surface Area: 101.88Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.53CX Basic pKa: CX LogP: 0.01CX LogD: 0.01
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -1.22

References

1. Das A, Dasgupta S, Pathak T..  (2022)  Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors.,  71  [PMID:35944385] [10.1016/j.bmc.2022.116888]

Source